Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Williams, K
We never rush the process and are always available to address your concerns after your session
The injury included bursitis and tears in the rotator cuff muscles (the supraspinatus and subscapularis)
RGN-352 was shown to be safe and well-tolerated with no serious drug-related adverse events reported (PMID: 20536472) Phase 2 AMI trial (incomplete): RegeneRx designed a Phase 2 proof-of-concept trial (NCT01311518) to evaluate RGN-352 in approximately 75 patients with acute ST-segment elevation myocardial infarction (heart attack)
/product/21/433141/1.jpg?2963)
US$ 19.98
US$ 28.44
US$ 27.26
US$ 22.27
US$ 21.66
US$ 23.48
